Arrowstreet Capital Limited Partnership Buys New Position in NewAmsterdam Pharma (NASDAQ:NAMS)

Arrowstreet Capital Limited Partnership purchased a new position in shares of NewAmsterdam Pharma (NASDAQ:NAMS – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 30,504 shares of the company’s stock, valued at approximately $784,000. Other institutional investors and hedge funds have also bought and sold shares of the company. Jennison Associates […]